Gå till innehåll

Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal

Reading Tips

A Swedish research programme worked to identify human pharmaceuticals that are likely to be of concern to aquatic ecosystems and address the risk for antibiotic resistance promotion in the environment. MistraPharma has also proposed risk management strategies, in particular improved regulatory test requirements and wastewater treatment technologies. Started in 2008 and ended in 2015.

Senast ändrad